Eris Lifesciences Limited (NSE:ERIS)

Eris Lifesciences Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	33,152	31,149	28,793	19,913	16,618	13,262
Revenue Growth	11.01%	8.18%	44.59%	19.83%	25.31%	11.20%
Gross Profit Gross Profit Growth	24,169	22,945	21,461	15,950	13,005	10,621
Operating Income Operating Income Growth	8,755	8,407	7,027	4,945	4,217	4,245
Net Income Net Income Growth	7,076	6,195	3,518	3,921	3,822	4,061
Earnings Per Share EPS Growth	51.28	45.26	25.81	28.79	28.07	29.88
EPS Growth	68.36%	75.36%	-10.35%	2.56%	-6.06%	14.31%

Revenue by Geography

Chart

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
India India Growth	27,733	26,375	19,448	16,618	13,262
outside India outside India Growth	3,416	2,418	465.2	-	-
Total Total Growth	31,149	28,793	19,913	16,618	13,262

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	2,541	555.2	2,055	13,389	860.29	2,123
Total Debt Total Debt Growth	24,295	23,586	24,779	27,813	8,918	936.66
Net Cash (Debt) Net Cash Growth	-21,754	-23,031	-22,725	-14,424	-8,058	1,187
Net Cash Growth	-	-	-	-	-	5.46%
Net Cash Per Share Net Cash Per Share Growth	-157.65	-168.26	-166.73	-105.93	-59.18	8.73

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	9,361	5,380	10,650	4,860	2,917	3,783
Capital Expenditures CapEx Growth	-4,005	-2,969	-1,550	-1,292	-8,414	-1,210
Free Cash Flow Free Cash Flow Growth	5,356	2,411	9,100	3,569	-5,497	2,572
Free Cash Flow Growth	-11.39%	-73.50%	155.01%	-	-	-26.42%

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	72.90%	73.66%	74.53%	80.10%	78.26%	80.09%
Operating Margin	26.41%	26.99%	24.40%	24.83%	25.37%	32.01%
Pretax Margin	19.31%	20.50%	16.98%	21.66%	24.35%	33.34%
Profit Margin	21.34%	19.89%	12.22%	19.69%	23.00%	30.62%
FCF Margin	16.16%	7.74%	31.61%	17.92%	-33.08%	19.40%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	7.210	7.210	7.350	-	7.350	6.010
Dividend Per Share Growth	0%	-1.91%	-	-	22.30%	9.27%
Dividend Yield	0.61%	0.56%	0.52%	-	1.29%	0.87%

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Oct 29, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	22.97	29.01	54.85	29.26	20.36	23.05
Forward PE	23.53	27.62	38.80	25.79	17.15	21.23
P/FCF Ratio	30.45	74.53	21.21	32.15	-	36.39
PS Ratio	4.92	5.77	6.70	5.76	4.68	7.06

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 29, 2026

Data Sources Report a data error